Form 8-K - Current report:
SEC Accession No. 0001558370-25-004605
Filing Date
2025-04-08
Accepted
2025-04-08 17:00:12
Documents
13
Period of Report
2025-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K capr-20250408x8k.htm   iXBRL 8-K 34585
  Complete submission text file 0001558370-25-004605.txt   150481

Data Files

Seq Description Document Type Size
2 EX-101.SCH capr-20250408.xsd EX-101.SCH 3253
3 EX-101.LAB capr-20250408_lab.xml EX-101.LAB 15264
4 EX-101.PRE capr-20250408_pre.xml EX-101.PRE 9652
15 EXTRACTED XBRL INSTANCE DOCUMENT capr-20250408x8k_htm.xml XML 4636
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 25822673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)